Adeno‐associated virus vector‐mediated systemic interleukin‐10 expression ameliorates hypertensive organ damage in Dahl salt‐sensitive rats
- 21 January 2008
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 10 (4), 368-374
- https://doi.org/10.1002/jgm.1166
Abstract
Background Inflammation plays an important role in the pathogenesis of hypertension and hypertensive organ damage. Interleukin (IL)‐10, a pleiotropic anti‐inflammatory cytokine, exerts vasculoprotective effects in many animal models. In the present study, we examined the preventive effects of adeno‐associated virus (AAV) vector‐mediated sustained IL‐10 expression against hypertensive heart disease and renal dysfunction in Dahl salt‐sensitive rats. Methods We injected the rats intramuscularly with an AAV type 1‐based vector encoding rat IL‐10 or enhanced green fluorescent protein (EGFP) at 5 weeks of age; subsequently, the rats were fed a high‐sodium diet from 6 weeks of age. Results Sustained IL‐10 expression significantly improved survival rate of Dahl salt‐sensitive rats compared with EGFP expression (62.5% versus 0%, p < 0.001); it also caused 26.0% reduction in systolic blood pressure at 15 weeks (p < 0.0001). Echocardiography exhibited a 22.0% reduction in hypertrophy (p < 0.0001) and a 26.3% improvement in fractional shortening (p < 0.0001) of the rat left ventricle in the IL‐10 group compared to the EGFP group. IL‐10 expression also caused a 21.7% decrease in the heart weight/body weight index and cardiac atrial natriuretic peptide levels. Histopathological studies revealed that IL‐10 decreased inflammatory cell infiltration, fibrosis, and transforming growth factor‐β1 levels in the failing heart. Furthermore, IL‐10 expression significantly reduced urine protein excretion with increased glomerular filtration rates. Conclusions This is the first study to demonstrate that the anti‐inflammatory cytokine IL‐10 has a significant anti‐hypertensive effect. AAV vector‐mediated IL‐10 expression potentially prevents the progression of refractory hypertension and hypertensive organ damage in humans. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
This publication has 31 references indexed in Scilit:
- Interleukin-10 Expression Mediated by an Adeno-Associated Virus Vector Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in RatsCirculation Research, 2007
- Immune suppression prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertensionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Immune Suppression Attenuates Hypertension and Renal Disease in the Dahl Salt-Sensitive RatHypertension, 2006
- Targeted Anticytokine Therapy in Patients With Chronic Heart FailureCirculation, 2004
- Interleukin-10 Induction of Nitric-oxide Synthase Expression Attenuates CD40-mediated Interleukin-12 Synthesis in Human Endothelial CellsJournal of Biological Chemistry, 2003
- Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart FailureCirculation, 2003
- Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial InfarctionCirculation, 2003
- Stress Hormones, Proinflammatory and Antiinflammatory Cytokines, and AutoimmunityAnnals of the New York Academy of Sciences, 2002
- Interleukin-10 Inhibits Human Vascular Smooth Muscle ProliferationJournal of Molecular and Cellular Cardiology, 1998
- Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart FailureNew England Journal of Medicine, 1990